CNS Oncology

Taylor & Francis Group

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

CNS Oncology is an open-access journal published by Taylor & Francis Group in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 1,800 USD. Declared review time at DOAJ: 13 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Taylor & Francis Group
ISSN
2045-0907 · 2045-0915
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
1,800 USD
Articles in DOAJ
131
Declared review time
13 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2019-03-11
  • MEDLINE · 2012-01-01
  • PUBMED · 2017-07-18
Indexing
DOAJ · MEDLINE · PUBMED
APC
1,800 USD
Declared review time (DOAJ)
13 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

131

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

13weeks

Works in OpenAlex

412

Last recorded publication year

2025

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

42

i10-index

182

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2024-11-09
Added to DOAJ
2019-03-11
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSLOCKSSPMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
100%
ORCID iDs in current deposits
73%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Central nervous system oncology
Source type
journal
NLM unique ID (PubMed)
101594668
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Glioma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Brain Metastases and Treatment
  • Meningioma and schwannoma management
  • Meningioma and schwannoma management
  • Neuroblastoma Research and Treatments
  • Neuroblastoma Research and Treatments
Show all subjects (50)
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Management of metastatic bone disease
  • Management of metastatic bone disease
  • CNS Lymphoma Diagnosis and Treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Neurofibromatosis and Schwannoma Cases
  • Neurofibromatosis and Schwannoma Cases
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Nanoplatforms for cancer theranostics
  • Nanoplatforms for cancer theranostics
  • Lung Cancer Treatments and Mutations
  • MRI in cancer diagnosis
  • MRI in cancer diagnosis
  • Cancer-related cognitive impairment studies
  • Histone Deacetylase Inhibitors Research
  • Cancer-related cognitive impairment studies
  • Histone Deacetylase Inhibitors Research
  • Radiomics and Machine Learning in Medical Imaging
  • Vascular Malformations Diagnosis and Treatment
  • Vascular Malformations Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer survivorship and care
  • Cancer survivorship and care
  • Cancer Immunotherapy and Biomarkers
  • Chromatin Remodeling and Cancer
  • Cancer Immunotherapy and Biomarkers
  • Chromatin Remodeling and Cancer
  • Ocular Oncology and Treatments
  • Epigenetics and DNA Methylation
  • MicroRNA in disease regulation
  • Cancer Genomics and Diagnostics
  • Epigenetics and DNA Methylation
  • MicroRNA in disease regulation
  • Ocular Oncology and Treatments
  • Cancer Genomics and Diagnostics
  • Childhood Cancer Survivors' Quality of Life
  • Childhood Cancer Survivors' Quality of Life

Keywords (DOAJ)

  • cns oncology
  • brain tumours
  • central nervous system tumours
  • malignant glioma

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: